Surgery Doctors in Oroville, CA Accepting Medicare

8 Surgery doctors found. Showing 1 - 8

Randell S Skau, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2809 Olive Hwy, Suite 220, Oroville, CA 95966 Phone: 530-532-8161    Fax: 530-538-3270

Zachary John Peckler, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2767 Olive Hwy, Oroville, CA 95966 Phone: 530-533-8500    Fax: 530-532-8370

Arturo P Pangilinan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2767 Olive Highway, Oroville, CA 95966 Phone: 530-589-4305    Fax: 530-589-3965

Mammen George Chandy, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2721 Olive Hwy, Suite 4, Oroville, CA 95966 Phone: 530-534-0750

Ms. Preeti Shenoy, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2809 Olive Hwy Ste 220, Oroville, CA 95966 Phone: 530-532-8161    Fax: 530-538-3270

Steven Francis Fletcher, MD Surgery Medicare: Medicare Enrolled Practice Location: 2809 Olive Highway, Suite 310, Oroville, CA 95966 Phone: 530-532-8161    Fax: 530-532-8433

Dr. Ravi Nagubandi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2809 Olive Hwy, Oroville, CA 95966 Phone: 646-401-3103

Chih Jung Shieh, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2630 Olive Hwy, Suite B, Oroville, CA 95966 Phone: 530-534-3037    Fax: 530-534-3384

News Archive

Immune checkpoint inhibitor increases survival in patients with advanced renal cell carcinoma

For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.

Abiomed announces new data from its USpella IRB registry of Impella 2.5 patients

Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new clinical data from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left ventricular support with the Impella 2.5 during high-risk percutaneous coronary intervention (PCI) and treatment of acute myocardial infarction (AMI).

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being covered are stenting in the femoral artery, polymer-free drug-eluting stents, valves and drug-eluting balloons used in angioplasty.

New mathematical model predicts biological process that creates antibody diversity

Scientists at USC have created a mathematical model that explains and predicts the biological process that creates antibody diversity - the phenomenon that keeps us healthy by generating robust immune systems through hypermutation.

Salmonella pathogen uses molecular hydrogen to grow and become virulent

New research, headed by microbiologists from the University of Georgia, show for the first time that Salmonella – a widespread and often deadly bacterial pathogen – use molecular hydrogen to grow and become virulent.

Read more Medical News

› Verified 9 days ago